Avandia (rosiglitazone) is manufactured by GlaxoSmithKline, and is a thiazolidinedione agent, a class of drugs approved by the FDA in 1998 to treat type 2 diabetes by helping control blood sugar levels. At its peak in 2006, 13.2 million people had taken Avandia. But by 2008, concerns over side effects had caused that number to fall to 4.6 million.
The Senate Finance Committee Avandia reports a damning profile of both GlaxoSmithKline and the FDA. Had either put the interests of patients first, thousands of Avandia-related heart attacks may have been prevented. Filing an Avandia heart attack lawsuit is one way victims of this drug can make sure GlaxoSmithKline is held accountable for the way it handled Avandia’s heart risks.
If you have taken Avandia and suffered serious side effects—you are not alone. Avandia has been linked to heart attacks, strokes, and congestive heart failure by the United States Food & Drug Administration (FDA). Avandia remains on the market—putting countless lives at risk. If you or a loved one has taken Avandia and suffered a heart attack, stroke or congestive heart failure, M&A law Firm would like to hear from you today. Call us at 1-866-789-1664 for a free consultation, or visit our Defective Drugs Class Action Lawsuits website.